AstraZeneca Takes First Step For Lynparza/Imfinzi Combo In Ovarian Cancer

First PARP plus PD1/L1-inhibitor Combo Data

 
• By Alexandra Shimmings
  
Female Reproductive System_1200
• Source: Shutterstock

More from Clinical Trials

More from R&D